Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Vyome Holdings ( (HIND) ) has issued an update.
On December 17, 2025, Vyome Holdings, Inc., through its indirect subsidiary LiveChain, Inc. (LICH), entered into a binding letter of intent with Remus Capital Series B II, L.P. to acquire a senior secured convertible note issued by Sociometric Solutions, Inc., d/b/a Humanyze, in exchange for issuing Remus a 25% fully diluted equity stake in LICH immediately prior to closing, with an additional 10% of LICH’s equity reserved for key and future employees, leaving current shareholders with an expected 65% post-closing stake. The transaction, treated as a related party deal and approved by both the company’s Audit Committee and Board after the recusal of Remus-affiliated directors, will be executed through a newly formed LICH subsidiary under a Note Purchase and Exchange Agreement, includes a $20,000 good-faith deposit to Humanyze, grants Remus the right to appoint one LICH director, and is structured to be completed within roughly 75 days of the LOI execution, potentially reshaping LICH’s capital structure and governance while ensuring Humanyze remains active to service select obligations.
The most recent analyst rating on (HIND) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on Vyome Holdings stock, see the HIND Stock Forecast page.
Spark’s Take on HIND Stock
According to Spark, TipRanks’ AI Analyst, HIND is a Underperform.
ReShape Lifesciences is facing significant financial challenges, with persistent losses, negative equity, and cash flow issues. The technical indicators show a bearish trend with potential oversold conditions. Valuation is poor due to a negative P/E ratio. Despite some positive developments highlighted in the earnings call, such as revenue growth and cost reductions, the overall outlook remains concerning due to financial instability and competitive pressures. The recent board resignation further complicates the situation by potentially affecting compliance and investor confidence.
To see Spark’s full report on HIND stock, click here.
More about Vyome Holdings
Vyome Holdings, Inc. operates through its indirect subsidiary LiveChain, Inc. (LICH), which structures and manages investments in technology-related assets, including positions in companies such as Sociometric Solutions, Inc. d/b/a Humanyze, and works with financial partners like Remus Capital to execute structured equity and debt transactions.
Average Trading Volume: 79,235
Technical Sentiment Signal: Strong Sell
Current Market Cap: $20.77M
See more insights into HIND stock on TipRanks’ Stock Analysis page.